Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Number of items: 36.

Bibliographic data only

Alexander, CE; Kaye, PM; Engwerda, CR; (2001) CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. European journal of immunology, 31 (4). pp. 1199-210. ISSN 0014-2980 https://researchonline.lshtm.ac.uk/id/eprint/16444 Full text not available from this repository.

Asres, K; Bucar, F; Knauder, E; Yardley, V; Kendrick, H; Croft, SL; (2001) In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytotherapy research, 15 (7). pp. 613-7. ISSN 0951-418X https://researchonline.lshtm.ac.uk/id/eprint/16573 Full text not available from this repository.

Ato, M; Stager, S; Engwerda, CR; Kaye, PM; (2002) Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nature immunology, 3 (12). pp. 1185-91. ISSN 1529-2908 DOI: https://doi.org/10.1038/ni861 Full text not available from this repository.

Babaloo, Z; Kaye, PM; Eslami, MB; (2001) Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th-2 and Th-1 cytokines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95 (1). pp. 85-8. ISSN 0035-9203 https://researchonline.lshtm.ac.uk/id/eprint/16442 Full text not available from this repository.

Bodman-Smith, KB; Mbuchi, M; Culley, FJ; Bates, PA; Raynes, JG; (2002) C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses. Parasite immunology, 24 (9-10). pp. 447-54. ISSN 0141-9838 DOI: https://doi.org/10.1046/j.1365-3024.2002.00486.x Full text not available from this repository.

Camacho, MR; Phillipson, JD; Croft, SL; Solis, PN; Marshall, SJ; Ghazanfar, SA; (2003) Screening of plant extracts for antiprotozoal and cytotoxic activities. Journal of ethnopharmacology, 89 (2-3). pp. 185-191. ISSN 0378-8741 DOI: https://doi.org/10.1016/s0378-8741(03)00269-1 Full text not available from this repository.

Chappuis, F; Sundar, S; Hailu, A; Ghalib, H; Rijal, S; Peeling, RW; Alvar, J; Boelaert, M; (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature reviews Microbiology, 5 (11). pp. 873-82. ISSN 1740-1526 DOI: https://doi.org/10.1038/nrmicro1748 Full text not available from this repository.

Daunes, S; D'Silva, C; Kendrick, H; Yardley, V; Croft, SL; (2001) QSAR study on the contribution of log P and E-s to the in vitro antiprotozoal activity of glutathione derivatives. Journal of medicinal chemistry, 44 (18). pp. 2976-83. ISSN 0022-2623 https://researchonline.lshtm.ac.uk/id/eprint/16567 Full text not available from this repository.

Engwerda, CR; Ato, M; Cotterell, SE; Mynott, TL; Tschannerl, A; Gorak-Stolinska, PM; Kaye, PM; (2002) A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. The American journal of pathology, 161 (2). pp. 429-37. ISSN 0002-9440 DOI: https://doi.org/10.1016/S0002-9440(10)64199-5 Full text not available from this repository.

Engwerda, CR; Ato, M; Stager, S; Alexander, CE; Stanley, AC; Kaye, PM; (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of leishmania donovani infection. The American journal of pathology, 165 (6). pp. 2123-33. ISSN 0002-9440 DOI: https://doi.org/10.1016/S0002-9440(10)63262-2 Full text not available from this repository.

Escobar, P; Yardley, V; Croft, SL; (2001) Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrobial agents and chemotherapy, 45 (6). pp. 1872-5. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.45.6.1872-1875.2001 Full text not available from this repository.

Guglielmo, S; Bertinaria, M; Rolando, B; Crosetti, M; Fruttero, R; Yardley, V; Croft, SL; Gasco, A; (2009) A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity. European journal of medicinal chemistry, 44 (12). pp. 5071-5079. ISSN 0223-5234 DOI: https://doi.org/10.1016/j.ejmech.2009.09.012 Full text not available from this repository.

Junghae, M; Raynes, JG; (2002) Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infection and immunity, 70 (9). pp. 5026-35. ISSN 0019-9567 DOI: https://doi.org/10.1128/iai.70.9.5026-5035.2002 Full text not available from this repository.

Khalil, EAG; Ayed, NB; Musa, AM; Ibrahim, ME; Mukhtar, MM; Zijlstra, EE; Elhassan, IM; Smith, PG; Kieny, PM; Ghalib, HW; +3 more... Zicker, F; Modabber, F; Elhassan, AM; (2005) Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clinical and experimental immunology, 140 (2). p. 349. ISSN 0009-9104 DOI: https://doi.org/10.1111/j.1365-2249.2005.02768.x Full text not available from this repository.

Khanal, B; Rijal, S; Ostyn, B; Picado, A; Gidwani, K; Menten, J; Jacquet, D; Lejon, V; Chappuis, F; Boelaert, M; (2010) Serological markers for Leishmania donovani infection in Nepal: agreement between direct agglutination test and rK39 ELISA. Tropical medicine & international health, 15 (11). pp. 1390-1394. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2010.02631.x Full text not available from this repository.

Khrizman, A; Moulthrop, JS; Little, S; Wharton, H; Yardley, V; Moyna, G; (2007) Synthesis and in vitro protozoocidal activity of diazabicyclic benzotropolone derivatives. Bioorganic & medicinal chemistry letters, 17 (15). pp. 4183-4186. ISSN 0960-894X DOI: https://doi.org/10.1016/j.bmcl.2007.05.044 Full text not available from this repository.

Kuhls, K; Mauricio, IL; Pratlong, F; Presber, W; Schonian, G; (2005) Analysis of ribosomal DNA internal transcribed spacer sequences of the Leishmania donovani complex. Microbes and infection / Institut Pasteur, 7 (11-12). pp. 1224-1234. ISSN 1286-4579 DOI: https://doi.org/10.1016/j.micinf.2005.04.009 Full text not available from this repository.

Loo, WJ; Lishman, SC; Lockwood, DN; Todd, PM; (2003) Case 2. Cutaneous leishmaniasis, leishmania amastigotes. Clinical and experimental dermatology, 28 (5). pp. 567-8. ISSN 0307-6938 DOI: https://doi.org/10.1046/j.1365-2230.2003.01360.x Full text not available from this repository.

Luque-Ortega, JR; Rivero-Lezcano, OM; Croft, SL; Rivas, L; (2001) In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism. Antimicrobial agents and chemotherapy, 45 (4). pp. 1121-1125. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.45.4.1121-1125.2001 Full text not available from this repository.

Martin, MB; Grimley, JS; Lewis, JC; Heath, HT; Bailey, BN; Kendrick, H; Yardley, V; Caldera, A; Lira, R; Urbina, JA; +4 more... Moreno, SNJ; Docampo, R; Croft, SL; Oldfield, E; (2001) Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy. Journal of medicinal chemistry, 44 (6). pp. 909-16. ISSN 0022-2623 https://researchonline.lshtm.ac.uk/id/eprint/16563 Full text not available from this repository.

Nan, A; Croft, SL; Yardley, V; Ghandehari, H; (2004) Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis. Journal of controlled release, 94 (1). pp. 115-127. ISSN 0168-3659 DOI: https://doi.org/10.1016/j.jconrel.2003.09.012 Full text not available from this repository.

Nan, A; Nanayakkara, NPD; Walker, LA; Yardley, V; Croft, SL; Ghandehari, H; (2001) N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs. Journal of controlled release, 77 (3). pp. 233-43. ISSN 0168-3659 https://researchonline.lshtm.ac.uk/id/eprint/16572 Full text not available from this repository.

Polley, R; Stager, S; Prickett, S; Maroof, A; Zubairi, S; Smith, DF; Kaye, PM; (2006) Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infection and immunity, 74 (1). pp. 773-776. ISSN 0019-9567 DOI: https://doi.org/10.1128/IAI.74.1.773-776.2006 Full text not available from this repository.

Reithinger, R; (2001) Skinny rodents, kala-azar and prostaglandin E2. Trends in parasitology, 17 (10). pp. 465-6. ISSN 1471-4922 https://researchonline.lshtm.ac.uk/id/eprint/18360 Full text not available from this repository.

Rijal, S; Uranw, S; Chappuis, F; Picado, A; Khanal, B; Paudel, IS; Andersen, EW; Meheus, F; Ostyn, B; Das, ML; +2 more... Davies, C; Boelaert, M; (2010) Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Tropical medicine & international health, 15. pp. 21-28. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2010.02518.x Full text not available from this repository.

Rijal, S; Yardley, V; Chappuis, F; Decuypere, S; Khanal, B; Singh, R; Boelaert, M; de Doncker, S; Croft, S; Dujardin, JC; (2007) Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes and infection / Institut Pasteur, 9 (4). pp. 529-535. ISSN 1286-4579 DOI: https://doi.org/10.1016/j.micinf.2007.01.009 Full text not available from this repository.

Singh, SP; Picado, A; Boelaert, M; Gidwani, K; Andersen, EW; Ostyn, B; Meheus, F; Rai, M; Chappuis, F; Davies, C; +1 more... Sundar, S; (2010) The epidemiology of Leishmania donovani infection in high transmission foci in India. Tropical medicine & international health, 15. pp. 12-20. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2010.02519.x Full text not available from this repository.

Yardley, V; Khan, AA; Martin, MB; Slifer, TR; Araujo, FG; Moreno, SN; Docampo, R; Croft, SL; Oldfield, E; (2002) In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrobial agents and chemotherapy, 46 (3). pp. 929-31. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.46.3.929-931.2002 Full text not available from this repository.

del Rayo Camacho, M; Phillipson, JD; Croft, SL; Kirby, GC; Warhurst, DC; Solis, PN; (2001) Terpenoids from Guarea rhophalocarpa. Phytochemistry, 56 (2). pp. 203-10. ISSN 0031-9422 https://researchonline.lshtm.ac.uk/id/eprint/15746 Full text not available from this repository.

del Rayo Camacho, M; Phillipson, JD; Croft, SL; Marley, D; Kirby, GC; Warhurst, DC; (2002) Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes. Journal of natural products, 65 (10). pp. 1457-61. ISSN 0163-3864 https://researchonline.lshtm.ac.uk/id/eprint/15748 Full text not available from this repository.

el Tai, NO; el Fari, M; Mauricio, I; Miles, MA; Oskam, L; el Safi, SH; Presber, WH; Schonian, G; (2001) Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Experimental parasitology, 97 (1). pp. 35-44. ISSN 0014-4894 DOI: https://doi.org/10.1006/expr.2001.4592 Full text not available from this repository.

Public

Elnaiem, DA; Hassan, MM; Maingon, R; Nureldin, GH; Mekawi, AM; Miles, M; Ward, RD; (2001) The Egyptian mongoose, Herpestes ichneumon, is a possible reservoir host of visceral leishmaniasis in eastern Sudan. Parasitology, 122 (Pt 5). pp. 531-6. ISSN 0031-1820 https://researchonline.lshtm.ac.uk/id/eprint/16246
[img]

Hailu, A; Musa, A; Wasunna, M; Balasegaram, M; Yifru, S; Mengistu, G; Hurissa, Z; Hailu, W; Weldegebreal, T; Tesfaye, S; +29 more... Makonnen, E; Khalil, E; Ahmed, O; Fadlalla, A; el-Hassan, A; Raheem, M; Mueller, M; Koummuki, Y; Rashid, J; Mbui, J; Mucee, G; Njoroge, S; Manduku, V; Musibi, A; Mutuma, G; Kirui, F; Lodenyo, H; Mutea, D; Kirigi, G; Edwards, T; Smith, P; Muthami, L; Royce, C; Ellis, S; Alobo, M; Omollo, R; Kesusu, J; Owiti, R; Kinuthia, J; (2010) Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial. PLoS neglected tropical diseases, 4 (10). ISSN 1935-2727 DOI: https://doi.org/10.1371/journal.pntd.0000709
[img]

Musa, AM; Younis, B; Fadlalla, A; Royce, C; Balasegaram, M; Wasunna, M; Hailu, A; Edwards, T; Omollo, R; Mudawi, M; +3 more... Kokwaro, G; el-Hassan, A; Khalil, E; (2010) Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study. PLoS neglected tropical diseases, 4 (10). ISSN 1935-2727 DOI: https://doi.org/10.1371/journal.pntd.0000855
[img]

Sundar, S; Jha, TK; Thakur, CP; Engel, J; Sindermann, H; Fischer, C; Junge, K; Bryceson, A; Berman, J; (2002) Oral miltefosine for Indian visceral leishmaniasis. The New England journal of medicine, 347 (22). pp. 1739-46. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa021556
[img]

This list was generated on Thu Jul 25 09:07:12 2019 BST.